HBM Holdings (HBM Holdings) Machinery, Furniture, Equipment : $15.31 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Machinery, Furniture, Equipment?

HBM Holdings's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was $15.31 Mil.

HBM Holdings's quarterly Machinery, Furniture, Equipment declined from Dec. 2022 ($14.75 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($15.31 Mil).

HBM Holdings's annual Machinery, Furniture, Equipment declined from Dec. 2021 ($16.76 Mil) to Dec. 2022 ($14.75 Mil) but then increased from Dec. 2022 ($14.75 Mil) to Dec. 2023 ($15.31 Mil).

HBM Holdings Machinery, Furniture, Equipment Historical Data

The historical data trend for HBM Holdings's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Machinery, Furniture, Equipment Chart

HBM Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

12.18

13.18

16.76

14.75

15.31

HBM Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial						16.76	-	14.75	-	15.31

HBM Holdings Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

HBM Holdings (HBM Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (OTCPK:HBMHF) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

02142:Hong Kong

Address

420 Fenglin Road, 12th Floor, Tower A, Fenglin International Plaza Phase II, Xuhui District, Shanghai, CHN, 200032

Website

https://www.harbourbiomed.com

HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.

HBM Holdings (HBM Holdings) Headlines

From GuruFocus

Harbour BioMed Announces Positive Profit Alert

By PRNewswire • 01-19-2024